These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Predicting peptides binding to MHC class II molecules using multi-objective evolutionary algorithms. Rajapakse M; Schmidt B; Feng L; Brusic V BMC Bioinformatics; 2007 Nov; 8():459. PubMed ID: 18031584 [TBL] [Abstract][Full Text] [Related]
25. NN-align. An artificial neural network-based alignment algorithm for MHC class II peptide binding prediction. Nielsen M; Lund O BMC Bioinformatics; 2009 Sep; 10():296. PubMed ID: 19765293 [TBL] [Abstract][Full Text] [Related]
26. A structural framework for deciphering the link between I-Ag7 and autoimmune diabetes. Corper AL; Stratmann T; Apostolopoulos V; Scott CA; Garcia KC; Kang AS; Wilson IA; Teyton L Science; 2000 Apr; 288(5465):505-11. PubMed ID: 10775108 [TBL] [Abstract][Full Text] [Related]
27. In silico prediction of peptide-MHC binding affinity using SVRMHC. Liu W; Wan J; Meng X; Flower DR; Li T Methods Mol Biol; 2007; 409():283-91. PubMed ID: 18450008 [TBL] [Abstract][Full Text] [Related]
28. Invariant chain peptides enhancing or inhibiting the presentation of antigenic peptides by major histocompatibility complex class II molecules. Adams S; Humphreys RE Eur J Immunol; 1995 Jun; 25(6):1693-702. PubMed ID: 7614997 [TBL] [Abstract][Full Text] [Related]
29. Binding of conserved islet peptides by human and murine MHC class II molecules associated with susceptibility to type I diabetes. Yu B; Gauthier L; Hausmann DH; Wucherpfennig KW Eur J Immunol; 2000 Sep; 30(9):2497-506. PubMed ID: 11009082 [TBL] [Abstract][Full Text] [Related]
30. The role of I-Ag7 beta chain in peptide binding and antigen recognition by T cells. Kanagawa O; Shimizu J; Unanue ER Int Immunol; 1997 Oct; 9(10):1523-6. PubMed ID: 9352357 [TBL] [Abstract][Full Text] [Related]
31. Rapid Identification of MHCII-Binding Peptides Through Microsphere-Assisted Peptide Screening (MAPS). Bugada LF; Smith MR; Wen F Methods Mol Biol; 2022; 2574():233-250. PubMed ID: 36087205 [TBL] [Abstract][Full Text] [Related]
32. Monoclonal antibody blocking the recognition of an insulin peptide-MHC complex modulates type 1 diabetes. Zhang L; Crawford F; Yu L; Michels A; Nakayama M; Davidson HW; Kappler JW; Eisenbarth GS Proc Natl Acad Sci U S A; 2014 Feb; 111(7):2656-61. PubMed ID: 24550292 [TBL] [Abstract][Full Text] [Related]
33. Toward the prediction of class I and II mouse major histocompatibility complex-peptide-binding affinity: in silico bioinformatic step-by-step guide using quantitative structure-activity relationships. Hattotuwagama CK; Doytchinova IA; Flower DR Methods Mol Biol; 2007; 409():227-45. PubMed ID: 18450004 [TBL] [Abstract][Full Text] [Related]
34. Invariant chain as a vehicle to load antigenic peptides on human MHC class I for cytotoxic T-cell activation. Wälchli S; Kumari S; Fallang LE; Sand KM; Yang W; Landsverk OJ; Bakke O; Olweus J; Gregers TF Eur J Immunol; 2014 Mar; 44(3):774-84. PubMed ID: 24293164 [TBL] [Abstract][Full Text] [Related]
35. Proteomic identification of MHC class I-associated peptidome derived from non-obese diabetic mouse thymus and pancreas. Wang L; Li X; Yang S; Chen X; Li J; Wang S; Zhang M; Zheng Z; Zhou J; Wang L; Wu Y J Proteomics; 2023 Jan; 270():104746. PubMed ID: 36210013 [TBL] [Abstract][Full Text] [Related]
36. A conformationally-constrained MHC class II I-Ag7-derived peptide protects NOD mice from the development of diabetes. Dunsavage MB; O'Leary CJ; Baumgart TD; Solvason N; Howard M; Lafferty K; Deshpande S; Reich EP J Autoimmun; 1999 Jun; 12(4):233-42. PubMed ID: 10330294 [TBL] [Abstract][Full Text] [Related]
37. USMPep: universal sequence models for major histocompatibility complex binding affinity prediction. Vielhaben J; Wenzel M; Samek W; Strodthoff N BMC Bioinformatics; 2020 Jul; 21(1):279. PubMed ID: 32615972 [TBL] [Abstract][Full Text] [Related]
38. Systematically benchmarking peptide-MHC binding predictors: From synthetic to naturally processed epitopes. Zhao W; Sher X PLoS Comput Biol; 2018 Nov; 14(11):e1006457. PubMed ID: 30408041 [TBL] [Abstract][Full Text] [Related]
39. Determination of a Predictive Cleavage Motif for Eluted Major Histocompatibility Complex Class II Ligands. Paul S; Karosiene E; Dhanda SK; Jurtz V; Edwards L; Nielsen M; Sette A; Peters B Front Immunol; 2018; 9():1795. PubMed ID: 30127785 [TBL] [Abstract][Full Text] [Related]
40. NetMHCIIpan-3.0, a common pan-specific MHC class II prediction method including all three human MHC class II isotypes, HLA-DR, HLA-DP and HLA-DQ. Karosiene E; Rasmussen M; Blicher T; Lund O; Buus S; Nielsen M Immunogenetics; 2013 Oct; 65(10):711-24. PubMed ID: 23900783 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]